Trial Profile
A Randomized phase II trial of chemoradiotherapy with UFT versus S-1 for low-grade rectal cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil (Primary)
- Indications Rectal cancer
- Focus Biomarker; Therapeutic Use
- 26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.
- 21 Jan 2012 Results presented at the 2012 Gastrointestinal Cancers Symposium.
- 06 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan